AngioDynamics, Inc.
ANGO
$10.36
$0.383.81%
NASDAQ
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.04% | 12.18% | 12.93% | -4.23% | -7.88% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.04% | 12.18% | 12.93% | -4.23% | -7.88% |
| Cost of Revenue | 5.19% | 10.03% | 16.86% | -15.70% | -15.13% |
| Gross Profit | 12.22% | 13.98% | 9.61% | 8.35% | -0.88% |
| SG&A Expenses | 2.58% | 11.14% | 4.83% | 0.12% | 3.67% |
| Depreciation & Amortization | 3.16% | 3.23% | 0.54% | -20.96% | -28.07% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.14% | 9.72% | 9.12% | -9.37% | -9.17% |
| Operating Income | 50.89% | 9.33% | 37.42% | 42.68% | 24.45% |
| Income Before Tax | 41.42% | 14.43% | 56.79% | 97.79% | 14.03% |
| Income Tax Expenses | 95.45% | -51.13% | 91.33% | 99.98% | -100.67% |
| Earnings from Continuing Operations | 40.86% | 14.81% | 55.02% | 97.65% | 63.03% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 40.86% | 14.81% | 55.02% | 97.65% | 63.03% |
| EBIT | 50.89% | 9.33% | 37.42% | 42.68% | 24.45% |
| EBITDA | 81.65% | 2.49% | 13.54% | 91.93% | 6,996.15% |
| EPS Basic | 41.73% | 15.88% | 55.64% | 97.69% | 63.67% |
| Normalized Basic EPS | 44.50% | 3.61% | 29.06% | 90.66% | 23.63% |
| EPS Diluted | 41.73% | 15.88% | 55.36% | 97.64% | 63.67% |
| Normalized Diluted EPS | 44.50% | 3.61% | 29.06% | 90.66% | 23.63% |
| Average Basic Shares Outstanding | 1.52% | 1.28% | 1.38% | 1.54% | 1.75% |
| Average Diluted Shares Outstanding | 1.52% | 1.28% | 1.38% | 1.54% | 1.75% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |